Sr. R&D Manager Meridian Life Science London, England, United Kingdom
Join us to explore the shift in oncology testing from centralized labs to decentralized, patient-focused care, driven by Meridian's innovations in molecular diagnostics. Discover next-generation molecular reagents for qPCR, isothermal amplification, and NGS library preparation, and how they are advancing patient-centric oncology diagnostics. Learn how using crude specimens like blood, urine, sputum, and stool in direct workflows shortens molecular testing times, improves test accessibility, and accelerates the development of cost-effective assays. We’ll also discuss how air-dried and lyophilized reagents support global access to molecular tests, making them suitable for point-of-care platforms and reducing resource-intensive shipping and storage.
